ArticleFrontiers in pharmacology2024

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation.

Sukanya B Jadhav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.